We found that the association of P/LP/D variants in BRCA2, ATM, PALB2, and NBN with prostate cancer risk in men of African ancestry varied by a man's PRS profile, with enhanced risk stratification for metastatic and aggressive prostate cancer, suggesting an additive effect of the PRS and carrier status. Here, PALB2 is linked to prostate cancer.